DE69214768T2 - Felbinac enthaltendes Arzneimittel - Google Patents

Felbinac enthaltendes Arzneimittel

Info

Publication number
DE69214768T2
DE69214768T2 DE69214768T DE69214768T DE69214768T2 DE 69214768 T2 DE69214768 T2 DE 69214768T2 DE 69214768 T DE69214768 T DE 69214768T DE 69214768 T DE69214768 T DE 69214768T DE 69214768 T2 DE69214768 T2 DE 69214768T2
Authority
DE
Germany
Prior art keywords
product containing
medicinal product
composition
containing felbinac
felbinac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69214768T
Other languages
English (en)
Other versions
DE69214768D1 (de
Inventor
Michael Peter Ramsey
Richard William Saunders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DE69214768D1 publication Critical patent/DE69214768D1/de
Publication of DE69214768T2 publication Critical patent/DE69214768T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Catching Or Destruction (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fertilizers (AREA)
  • Inorganic Fibers (AREA)
  • Compounds Of Iron (AREA)
DE69214768T 1991-10-01 1992-08-03 Felbinac enthaltendes Arzneimittel Expired - Lifetime DE69214768T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9120831A GB2260079B (en) 1991-10-01 1991-10-01 Pharmaceutical composition containing felbinac

Publications (2)

Publication Number Publication Date
DE69214768D1 DE69214768D1 (de) 1996-11-28
DE69214768T2 true DE69214768T2 (de) 1997-05-28

Family

ID=10702242

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69214768T Expired - Lifetime DE69214768T2 (de) 1991-10-01 1992-08-03 Felbinac enthaltendes Arzneimittel

Country Status (22)

Country Link
EP (1) EP0535327B1 (de)
JP (1) JP3268852B2 (de)
KR (1) KR930007444A (de)
CN (1) CN1042394C (de)
AT (1) ATE144414T1 (de)
AU (1) AU2609592A (de)
CA (1) CA2079420A1 (de)
CZ (1) CZ281758B6 (de)
DE (1) DE69214768T2 (de)
DK (1) DK0535327T3 (de)
ES (1) ES2093747T3 (de)
FI (1) FI106842B (de)
GB (1) GB2260079B (de)
GR (1) GR3021439T3 (de)
HK (1) HK22396A (de)
HU (2) HU217544B (de)
IL (1) IL103288A (de)
MX (1) MX9205389A (de)
NO (1) NO300615B1 (de)
NZ (1) NZ244470A (de)
SK (1) SK279113B6 (de)
ZA (1) ZA927531B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
WO2007039825A2 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
CN1944378A (zh) * 2006-10-23 2007-04-11 广东中科药物研究有限公司 一种联苯乙酸氨丁三醇盐及其制备方法
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
AR073346A1 (es) * 2009-07-21 2010-11-03 Silva Pablo Cesar Composicion formadora de espuma para la generacion de senalizaciones de duracion temporal acotada
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011039637A2 (en) 2009-10-02 2011-04-07 Foamix Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
EP2544662B1 (de) 2010-03-10 2020-05-20 Nuvo Pharmaceuticals Inc. Schäumbare formulierung
CN104262138B (zh) * 2014-08-22 2016-05-11 湖北美林药业有限公司 一种联苯乙酸化合物及其药物组合物
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
CN109568300A (zh) * 2018-12-11 2019-04-05 石家庄以岭药业股份有限公司 联苯乙酸或其盐在制备Xa抑制剂药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
US4847069A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel
JPH07112984B2 (ja) * 1989-04-28 1995-12-06 久光製薬株式会社 泡状エアゾール製剤
CA2042583C (en) * 1989-07-28 1995-06-20 Akira Nakagawa Foamable aerosol preparation

Also Published As

Publication number Publication date
NO923809D0 (no) 1992-09-30
EP0535327A1 (de) 1993-04-07
HUT62470A (en) 1993-05-28
CN1042394C (zh) 1999-03-10
GB2260079B (en) 1995-08-09
HU9203112D0 (en) 1992-12-28
GB9120831D0 (en) 1991-11-13
NO923809L (no) 1993-04-02
HU211697A9 (en) 1995-12-28
KR930007444A (ko) 1993-05-20
SK271692A3 (en) 1995-11-08
FI924392A (fi) 1993-04-02
CN1073094A (zh) 1993-06-16
DK0535327T3 (da) 1996-11-18
ATE144414T1 (de) 1996-11-15
CZ281758B6 (cs) 1997-01-15
FI106842B (fi) 2001-04-30
CZ271692A3 (en) 1993-04-14
ES2093747T3 (es) 1997-01-01
ZA927531B (en) 1993-05-06
NO300615B1 (no) 1997-06-30
MX9205389A (es) 1993-05-01
GR3021439T3 (en) 1997-01-31
SK279113B6 (sk) 1998-06-03
JP3268852B2 (ja) 2002-03-25
FI924392A0 (fi) 1992-09-30
HU217544B (hu) 2000-02-28
EP0535327B1 (de) 1996-10-23
IL103288A0 (en) 1993-02-21
JPH05194208A (ja) 1993-08-03
HK22396A (en) 1996-02-16
AU2609592A (en) 1993-04-08
CA2079420A1 (en) 1993-04-02
NZ244470A (en) 1993-08-26
IL103288A (en) 1997-06-10
DE69214768D1 (de) 1996-11-28
GB2260079A (en) 1993-04-07

Similar Documents

Publication Publication Date Title
DE69214768D1 (de) Felbinac enthaltendes Arzneimittel
DE3679722D1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
KR880009662A (ko) Igf-ii함유 약제
CA2095223A1 (en) Topical compositions for transdermal delivery of prodrug derivatives of morphine
ZA9510876B (en) Transdermal absorption of active substances
DE69214938T2 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
AR002030A1 (es) Composiciones farmaceuticas para administracion a la piel o a las mucosas, y uso de una combinacion de aciclovir e hidrocortisona para la elaboracion de medicamentos
ATE138569T1 (de) Topisch anzuwendendes arzneimittel enthaltend ketoprofenlysinat
AR007090A1 (es) Formula para administracion subcutanea que contiene fentanilo presentada en forma de cinta
AU4697393A (en) Pharmaceutical and/or cosmetic preparation and the use of the preparation
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
GB9212450D0 (en) New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES2061989T3 (es) Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis.
ATE204474T1 (de) Amethocain enthaltende arzneimittel
TW259711B (en) Pharmaceutical composition containing 4-biphenylacetic acid
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
GB1418019A (en) Antimicrobial compositions
MY110416A (en) Composition for the treatment of schizophrenia.
GT199100015A (es) Metodo para administracion percutanea de ibuprofeno usando un gel hidroalcoholico

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WYETH HOLDINGS CORP., MADISON, N.J., US